About Legal TB-500
The name began with a question that sounds easier than it is: what does “legal” actually settle?
Why this case exists
I expected the legal record to be the straightforward part. The withdrawn FDA nomination complicated that expectation. The entry changed the category status while leaving the consequential question of routine compounding access unresolved. A clean verdict would have been satisfying. The paperwork gave me something more interesting to examine.
Legal TB-500 is this personal casebook about peptide claims and public records. No professional practice operates here. I offer neither medical nor legal advice, and this site has no products to purchase, treatment to prescribe, parcels to dispatch or appointments to book. The word “Legal” names the subject under examination.
The findings that persuaded me
I consider the rat wound result a substantial piece of experimental biology for full-length thymosin beta-4. The mouse muscle result makes me much more demanding about what a repair claim promises: the fibres regenerated, while strength and cardiac function showed no significant improvement.
The muscle paper corrected my earlier enthusiasm for regeneration as an outcome in itself. Cell movement, a new fibre and better function each matter, yet they answer different questions. The substance matters too. Much of TB-500’s reputation draws on experiments with the larger protein. The horse detection work is unusually specific about the short fragment’s identity, even though its purpose was anti-doping analysis.
The unanswered part
A controlled human study of the fragment, with verified material and functional outcomes, would move this file forward. The existing human cardiac registry entry concerns full-length thymosin beta-4 and leaves no posted outcome in the record available here. There is still a substantial gap between a plausible repair mechanism and a dependable clinical result.
I can leave a case unresolved. A confident answer assembled from incompatible exhibits is harder to accept. The source list is the place to pursue a particular paper; the contact page explains the information needed to identify a source error.